A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting · NCT05757869 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT05757869 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Janssen Research & Development, LLC | 188 |
1,051 results · Page 1 of 43
Research sites
Swipe the table sideways for more columns.